Buy Sun Pharma; target Rs 569: Angel Broking

21082 Investors following Sun Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Buy Sun Pharma; target Rs 569: Angel Broking

Angel Broking is bullish on Sun Pharma and has recommended buy rating on the stock with a target price of Rs 569 in its November 16, 2011 research report.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Buy Lupin; target of Rs 593: Angel Broking Buy Power Finance Corp; target Rs 207: Unicon Investment Buy Syndicate Bank; target Rs 128: Hedge Equities ALSO READ See previous views by Angel Broking See what other Experts & Brokerages are saying about Sun Pharma See messages about Sun Pharma Sun Pharma BSE | NSE 31/05/12 Are Mutual Funds betting on Sun Pharma?

Angel Broking is bullish on Sun Pharma and has recommended buy rating on the stock with a target price of Rs 569 in its November 16, 2011 research report.

"Sun Pharma reported higher-than-expected 2QFY2012 performance. Net sales reported 38.3% yoy growth. Net profit grew by 18.7% yoy, driven by higherthan- expected improvement in OPM. For 2QFY2012, Sun Pharma reported net sales of Rs 1,895cr, up 38.3% yoy, mainly driven by the inclusion of Taro's financials as well as strong growth in overall exports. The company's OPM expanded to 41.4% in 2QFY2012 from 34.1% in 2QFY2011. Gross margin increased to 80.8% in 2QFY2012 from 75.4% in 2QFY2011. The improvement in OPM was higher than gross margin improvement because of lower other expenses during the quarter. Net profit during the quarter reported 18.7% yoy growth to Rs 598cr."

"Sun Pharma is one of the largest and fastest growing Indian pharmaceutical companies. Management has guided for 28-30% top-line growth for FY2012. Growth reported during the year can also be attributed to the consolidation of Taro's financials. Management's guidance for FY2012E includes all growth aspects from Taro as well. We expect Sun Pharma's net sales to post a 27.3% CAGR to Rs 9,272cr and EPS to register a 21.4% CAGR to Rs 25.9 over FY2011-13E. We recommend a Buy rating on the stock with a target price of Rs 569," says Angel Broking research report.

Public holding more than 90% in Indian cos

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click on the attachment